Clinical trial data shows RAD 101 detects Brain Metastases

by admin February 10, 2025

February 10, 2025

Radiopharm Theranostics (RAD:AU) has announced Clinical trial data shows RAD 101 detects Brain Metastases

Download the PDF here.

This post appeared first on investingnews.com

0

Facebook Twitter Google +Pinterest

Nevada Organic Phosphate

Silver47 Drills 2.48m of 14.95 g/t Gold, 249.50...

Gold Rally Sparks Renewed Investor Rush Into Mining...

Top 4 Vanadium-producing Countries (Updated 2024)

Frank Holmes: Gold Wakeup Call in Progress, US$3,000...

New High-Grade 35% Copper and 10g/t Gold Rock...

CHARBONE Hydrogen Addresses Temporary Service Disruption at Legacy...

Lode Gold Closes $350,000 Financing

Top 5 Small-cap Pharma Stocks (Updated January 2025)

Canadian North Resources Inc. to Participate at Mines...

Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

Latest

FLASHBACK: Musk accused Trump, GOP leaders of not wanting to cut spending...
‘Right down the line’: Medicaid reform in ‘big, beautiful bill’ divides lawmakers by party
Thai hostage recovered from southern Gaza in military operation
Kharkiv hit by ‘most powerful attack’ of entire war, mayor says, as Russia pounds Ukraine again
TSA tells Americans their Costco cards won’t fly at airport security despite love for hot dogs

Categories

Business (1,690)
Investing (5,061)
Politics (7,968)
Uncategorized (2)
World (6,437)

About us
Contacts
Privacy Policy
Terms & Conditions
Email Whitelisting

Disclaimer: trendfutureincome.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Back To Top

Clinical trial data shows RAD 101 detects Brain Metastases

MOU signed with Lafarge Canada Inc.

High-Grades up to 65g/t Au at Second Fortune Gold Mine

You may also like